Home › Funds › INTREPID FAMILY OFFICE LLC › ORGO
INTREPID FAMILY OFFICE LLC position in ORGO
ORGANOGENESIS HLDGS INC · Health Care
INTREPID FAMILY OFFICE LLC reported holding 45,350 shares of ORGO (ORGANOGENESIS HLDGS INC) in its Q2 2026 13F filing — a position valued at US$110K, representing 0.09% of its reported portfolio and ranking #34 among its reported holdings. INTREPID FAMILY OFFICE LLC has disclosed ORGO holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How INTREPID FAMILY OFFICE LLC's ORGO position evolved
INTREPID FAMILY OFFICE LLC first disclosed a stake in ORGO in Q4 2024 at 105,000 shares (US$336K). The position peaked in Q4 2025 at 100,000 shares, worth US$518K. Across 7 filings, INTREPID FAMILY OFFICE LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 45,350 shares valued at US$110K — a reduction of -28,230 shares quarter over quarter.. Notable position changes include a 27% trim in Q3 2025 (shares rose 23% over the following quarter), a 26% trim in Q1 2026 (shares rose 3% over the following quarter), a 38% trim in Q2 2026 (shares fell 44% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 105.00K | $336.00K | New |
| Q1 2025 | 100.00K | $432.00K | Reduce |
| Q2 2025 | 110.00K | $402.60K | Add |
| Q3 2025 | 80.10K | $338.02K | Reduce |
| Q4 2025 | 100.00K | $518.00K | Add |
| Q1 2026 | 73.58K | $174.38K | Reduce |
| Q2 2026 | 45.35K | $110.20K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORGO and 13F data
ORGO (ORGANOGENESIS HLDGS INC) is a Health Care company. 26 other funds we track also report a position in ORGO — the largest reported positions include Soleus Capital Management, L.P. (US$24.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORGO
- Soleus Capital Management, L.P. 10.14M sh · $24.64M · Q2 2026
More on INTREPID FAMILY OFFICE LLC
FAQ
How long has INTREPID FAMILY OFFICE LLC held ORGO?
INTREPID FAMILY OFFICE LLC has disclosed ORGO holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is INTREPID FAMILY OFFICE LLC's current position in ORGO?
As of Q2 2026, INTREPID FAMILY OFFICE LLC holds 45.35K shares of ORGO (ORGANOGENESIS HLDGS INC), valued at $110.20K, representing 0.09% of its reported portfolio and ranking #34.
Has INTREPID FAMILY OFFICE LLC been buying or selling ORGO?
In the latest 13F filing (Q2 2026), INTREPID FAMILY OFFICE LLC reduced its position in ORGO. The position peaked in Q4 2025 at 100.00K shares.
Which other funds hold ORGO?
Other major institutional holders of ORGO include Soleus Capital Management, L.P., among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.